Armen Aprikian, MD
Primary Axis:
Cancer Research Focus:
Research is focused on neuroendocrine differentiation, neuropeptides and prostate cancer progression via focal adhesion kinase activation. In addition, clinical epidemiology of prostate cancer risk and progression including the study of non-steroidal anti-inflammatory use in men at risk of prostate carcinogenesis. Finally, clinical outcomes after radical cystectomy for invasive transitional cell carcinoma of the bladder.Prostate cancer, metastases, neuropeptides, epidemiology, progression, bladder cancer
Email:
Email contact form Keywords:
Prostate cancer, metastases, neuropeptides, epidemiology, progression, bladder cancer
Location:
Montreal General Hospital Publications:
Lacoste J, Aprikian AG, Chevalier S. Focal Adhesion Kinase is required for bombesin-induced prostate cancer cell motility. Molecular and Cellular Endocrinology 2005; 235: 51-61.
Mahmud S, Franco E, Aprikian AG. Prostate Cancer and Use of Non-Steroidal Anti-Inflammatory Drugs: Systematic Review and Meta-Analysis. British Journal of Cancer 2004; 90:93-99.
Karakiewicz PI, Kattan M, Foulkes W, Tanguay S, Scardino P, Elhilali M, Aprikian AG. Familial prostate and breast cancer in men treated with postatectomy for prostate cancer: population based case-control study. Journal of Urology 2003; 169:240-244.
